Richard C. Mulligan

52.1k citations

202 papers · 41.2k indexed · 20 hit papers · h-index 85

Molecular Biology top 0.05%
Genetics top 0.02%
Oncology top 0.1%
Immunology top 0.1%
Surgery top 0.5%

Co-authors: Daniel Ory Katja Brose Margaret A. Goodell David Baltimore G Paradis Richard S. Mann Didier Trono Philippe Gallay
Topics: Virus-based gene therapy research (71 papers)RNA Interference and Gene Delivery (34 papers)Immunotherapy and Immune Responses (32 papers)
Cited by: Genetics Immunology
Journals: Nature Science Cell
Partner nations: United States France Belgium

In The Last Decade

Richard C. Mulligan

200 papers receiving 39.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

1996 3.9k citations Richard C. Mulligan et al. profile →
Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

1993 2.3k citations Richard C. Mulligan et al. Proceedings of the National Academy of Sciences profile →
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

1996 2.2k citations Richard C. Mulligan et al. The Journal of Experimental Medicine profile →
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus

1983 1.6k citations Richard C. Mulligan et al. profile →
Dystrophin expression in the mdx mouse restored by stem cell transplantation

1999 1.4k citations Richard C. Mulligan et al. Nature profile →
The Basic Science of Gene Therapy

1993 1.4k citations Richard C. Mulligan profile →
"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells

2002 1.3k citations Yumi Matsuzaki, Richard C. Mulligan et al. profile →
Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene

1991 1.2k citations Victor L. J. Tybulewicz, Richard C. Mulligan et al. profile →
PTH/PTHrP Receptor in Early Development and Indian Hedgehog—Regulated Bone Growth

1996 1.0k citations Richard C. Mulligan et al. profile →
Engineering vascularized skeletal muscle tissue

2005 963 citations Richard C. Mulligan et al. profile →
Demonstration That CFTR Is a Chloride Channel by Alteration of Its Anion Selectivity

1991 920 citations Matthew P. Anderson, Richard J. Gregory et al. profile →
Construction and applications of a highly transmissible murine retrovirus shuttle vector

1984 913 citations Richard C. Mulligan et al. profile →
Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene.

1994 895 citations Victor L. J. Tybulewicz, Richard C. Mulligan et al. profile →
Physiological consequences of loss of plasminogen activator gene function in mice

1994 881 citations Peter Carmeliet, Luc Schoonjans et al. Nature profile →
Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species

1997 879 citations Richard C. Mulligan et al. Nature Medicine profile →
A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes.

1996 815 citations Richard C. Mulligan et al. Proceedings of the National Academy of Sciences profile →
Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.

1988 781 citations Richard C. Mulligan et al. Proceedings of the National Academy of Sciences profile →
Developmental potential and dynamic behavior of hematopoietic stem cells

1986 725 citations Richard C. Mulligan et al. profile →
Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis

1994 694 citations Glenn Dranoff, Richard C. Mulligan et al. profile →
Synthesis of rabbit β-globin in cultured monkey kidney cells following infection with a SV40 β-globin recombinant genome

1979 283 citations Richard C. Mulligan et al. Nature profile →

Peers

Countries citing papers authored by Richard C. Mulligan

Since Specialization

Citations

This map shows the geographic impact of Richard C. Mulligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Mulligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Mulligan more than expected).

Fields of papers citing papers by Richard C. Mulligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Mulligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Mulligan. The network helps show where Richard C. Mulligan may publish in the future.

Co-authorship network of co-authors of Richard C. Mulligan

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Mulligan. A scholar is included among the top collaborators of Richard C. Mulligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Mulligan. Richard C. Mulligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Attention-Deficit/Hyperactivity Disorder, Autistic Traits, and Substance Use Among Missouri Adolescents 2013 ·SHILAP Revista de lepidopterología ·Richard C. Mulligan,Angela M. Reiersen,Alexandre A. Todorov	10
2	Detecting T-cell reactivity to whole cell vaccines 2012 ·OncoImmunology ·(unknown),Ursula Hainz,Martha Wadleigh,Donna Neuberg,Mei Su,Christine Canning,Daniel J. DeAngelo,Richard M. Stone,Jeng-Shin Lee,Richard C. Mulligan,Jerome Ritz,Glenn Dranoff,Tetsuro Sasada,Catherine J. Wu	14
3	Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome 2008 ·Journal of Clinical Investigation ·Karyn M. Austin,Mohan L. Gupta,Scott A. Coats,Asmin Tulpule,Gustavo Mostoslavsky,Alejandro B. Balazs,Richard C. Mulligan,George Q. Daley,David Pellman,Akiko Shimamura	95
4	Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells 2007 ·Leukemia ·Aleksandra M. Glodek,Yi Le,Derek M. Dykxhoorn,Shin‐Young Park,Gustavo Mostoslavsky,Richard C. Mulligan,Judy Lieberman,Hilary E. Beggs,Marek Honczarenko,Leslie E. Silberstein	53
5	Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer 2006 ·Proceedings of the National Academy of Sciences ·Gustavo Mostoslavsky,Attila J. Fabian,Seán Rooney,Frederick W. Alt,Richard C. Mulligan	129
6	Exogenous control of mammalian gene expression via modulation of translational termination 2006 ·Nature Medicine ·George J. Murphy,Gustavo Mostoslavsky,Darrell N. Kotton,Richard C. Mulligan	46
7	Exogenous control of mammalian gene expression through modulation of RNA self-cleavage 2004 ·Nature ·Laising Yen,Jennifer M. Svendsen,Jeng-Shin Lee,John T. Gray,(unknown),Takashi Baba,Robert J. D’Amato,Richard C. Mulligan	210
8	Unexpectedly Efficient Homing Capacity of Purified Murine Hematopoietic Stem Cells 2004 ·Immunity ·Yumi Matsuzaki,Kentaro Kinjo,Richard C. Mulligan,Hideyuki Okano	224
9	Gene therapy to target dendritic cells from blood to lymph nodes 2003 ·Gene Therapy ·Caroline Robert,Christoph Klein,Guijuan Cheng,(unknown),Richard C. Mulligan,Ulrich H. von Andrian,Thomas S. Kupper	23
10	Glucose-induced Toxicity in Insulin-producing Pituitary Cells That Coexpress GLUT2 and Glucokinase 2001 ·Journal of Biological Chemistry ·Raquel N. Faradji,Evis Havari,Qian Chen,(unknown),Keith Tornheim,Barbara E. Corkey,Richard C. Mulligan,Myra A. Lipes	21
11	Expression of Bcl-XL Restores Cell Survival, but Not Proliferation and Effector Differentiation, in Cd28-Deficient T Lymphocytes 2000 ·The Journal of Experimental Medicine ·(unknown),Christoph Klein,Pietro G. Andres,Cheryl A. London,(unknown),Richard C. Mulligan,Abul K. Abbas	51
12	Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies 2000 ·Cancer Chemotherapy and Pharmacology ·William G. Nelson,Jonathan W. Simons,Bahar Mikhak,(unknown),Angelo M. De Marzo,(unknown),Michael Kim,(unknown),Angelo A. Baccala,(unknown),S Clift,Dale Ando,Hyam I. Levitsky,L. Cohen,Martin G. Sanda,Richard C. Mulligan,Alan W. Partin,H. Ballentine Carter,(unknown),Fray F. Marshall	62
13	Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. 1996 ·Journal of Clinical Investigation ·(unknown),William M. Hull,Glenn Dranoff,Richard C. Mulligan,J. A. Whitsett	207
14	Gene Transfer as Cancer Therapy 1995 ·Advances in immunology ·(unknown),Richard C. Mulligan	110
15	A biochemical and ultrastructural evaluation of the type 2 Gaucher mouse 1995 ·Molecular and Chemical Neuropathology ·Rob Willemsen,Victor L. J. Tybulewicz,Ellen Sidransky,William K. Eliason,Brian M. Martin,Mary E. LaMarca,A. J. J. Reuser,Michel L. Tremblay,H Westphal,Richard C. Mulligan,Edward I. Ginns	34
16	Transgenic animals as tools for the study of fibrinolysis in vivo 1994 ·Journal of Internal Medicine ·Peter Carmeliet,Richard C. Mulligan,D Collen	7
17	Biological Effects of Disruption of the Tissue‐Type Plasminogen Activator, Urokinase‐Type Plasminogen Activator, and Plasminogen Activator Inhibitor‐1 Genes in Mice^a 1994 ·Annals of the New York Academy of Sciences ·Peter Carmeliet,Ann Bouché,(unknown),Sara Janssen,Saskia Pollefeyt,Sabine Wyns,Richard C. Mulligan,D Collen	54
18	Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization. 1993 ·Journal of Clinical Investigation ·Peter Carmeliet,L Kieckens,Luc Schoonjans,(unknown),(unknown),George C. Prendergast,Michael D. Cole,(unknown),Désiré Collen,Richard C. Mulligan	292
19	Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. 1991 ·Journal of Clinical Investigation ·Herbert A. Berger,Matthew P. Anderson,Richard J. Gregory,Simon Thompson,Paul W. Howard,Russell Maurer,Richard C. Mulligan,Alan E. Smith,Michael J. Welsh	208
20	Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. 1987 ·The Journal of Experimental Medicine ·David A. Williams,K HSIEH,(unknown),Richard C. Mulligan	120

About Richard C. Mulligan

Richard C. Mulligan is a scholar working on Genetics, Immunology and Hematology, having authored 202 papers that have together received 41.2k indexed citations. Recurring topics across this work include Virus-based gene therapy research (71 papers), RNA Interference and Gene Delivery (34 papers) and Immunotherapy and Immune Responses (32 papers). The work is most often cited by research in Genetics (11.9k citations), Immunology (8.6k citations) and Genetics (4.0k citations). Richard C. Mulligan has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Daniel Ory, Katja Brose, Margaret A. Goodell, David Baltimore, G Paradis, Richard S. Mann, Didier Trono, Philippe Gallay, Inder M. Verma and Luigi Naldini. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact